Monday, January 09, 2017 1:16:02 PM
PR Newswire PR NewswireJanuary 5, 2017Comment
LOS ANGELES, Jan. 5, 2017 /PRNewswire/ -- OriginClear Inc. (OTC/QB: OCLN), a leading provider of water treatment solutions, today announced that it has responded to EU-level water infrastructure mandates by African governments by working with French engineering company UltraEpur.
"UltraEpur contacted us to help rapidly clear up contaminated industrial water, beginning in Algeria, where the government intends to upgrade to developed-world water standards rapidly," said "JL" Kindler, President of OriginClear Technologies. "We have since entered a technology license agreement, and UltraEpur purchased a laboratory demonstration unit, which it plans to exhibit at the SIEE Pollutec trade show in Algiers in February."
"We identified OriginClear's EWS:AOx™ as a perfectly complementary upstream treatment solution for our filtration systems," said Thierry Vignal, founder and principal of UltraEpur. "We have already integrated OriginClear into our planned pilot system for an Algerian industrial site that must meet stringent new water regulations effluents that exceed 4000 m3 per day (or more than one million gallons daily)."
"In a conservative water industry, we look for fast-adopters that intend to respond to intense demand in their regions," added Kindler "We're delighted to add UltraEpur to the ranks of these visionaries."
According to founder Vignal, UltraEpur is active in France, where it is headquartered, but also in North Africa and French-speaking Western African countries such as Ivory Coast.
While UltraEpur is not relying on government funding for its commercial activities, development of the country's water supply system is a high priority for the Algerian government in its new five-year plan.
Recent OCLN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/08/2023 10:27:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 07:36:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 07:34:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/25/2023 07:21:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 09:20:48 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM